CCS ASSOCIATES, INC.

Address: 2107 N 1ST ST SAN JOSE, CA 95131-2026
County: SANTA CLARA
Country: UNITED STATES
UEI: VCNRS52G5PG7

Issue Date FY

Legal Entity Zip Code

Issue Date FY: 2024 ( Subtotal = $0 )

2024

2022

CCS ASSOCIATES, INC.

2107 N 1ST ST

SAN JOSE

95131-2026

SANTA CLARA

USA

U01FD007470

DDTBMQ000011: Advance tumor volume change as measured by CT as a pharmacodynamic biomarker for new oncologic drug clinical trial therapy of solid tumors to Stage 2 of FDA biomarker qualification

000

FDA

9/24/2024

Issue Date FY: 2023 ( Subtotal = $0 )

2023

2022

CCS ASSOCIATES, INC.

2107 N 1ST ST STE 640

SAN JOSE

95131-2026

SANTA CLARA

USA

U01FD007470

DDTBMQ000011: Advance tumor volume change as measured by CT as a pharmacodynamic biomarker for new oncologic drug clinical trial therapy of solid tumors to Stage 2 of FDA biomarker qualification

000

FDA

8/9/2023

Issue Date FY: 2022 ( Subtotal = $0 )

2022

CCS ASSOCIATES, INC.

2107 N 1ST ST STE 640

SAN JOSE

95131-2026

SANTA CLARA

USA

U01FD007470

DDTBMQ000011: Advance tumor volume change as measured by CT as a pharmacodynamic biomarker for new oncologic drug clinical trial therapy of solid tumors to Stage 2 of FDA biomarker qualification

001

FDA

2/10/2022

$248,614

2022

CCS ASSOCIATES, INC.

2107 N 1ST ST STE 640

SAN JOSE

95131-2026

SANTA CLARA

USA

U01FD007470

DDTBMQ000011: Advance tumor volume change as measured by CT as a pharmacodynamic biomarker for new oncologic drug clinical trial therapy of solid tumors to Stage 2 of FDA biomarker qualification

002

FDA

8/16/2022

2022

CCS ASSOCIATES, INC.

2107 N 1ST ST STE 640

SAN JOSE

95131-2026

SANTA CLARA

USA

U01FD007470

DDTBMQ000011: Advance tumor volume change as measured by CT as a pharmacodynamic biomarker for new oncologic drug clinical trial therapy of solid tumors to Stage 2 of FDA biomarker qualification

000

FDA

2/8/2022

-$248,614

Issue Date FY: 2021 ( Subtotal = $248,614 )

2021

2022

CCS ASSOCIATES, INC.

2107 N 1ST ST STE 640

SAN JOSE

95131-2026

SANTA CLARA

USA

U01FD007470

DDTBMQ000011: Advance tumor volume change as measured by CT as a pharmacodynamic biomarker for new oncologic drug clinical trial therapy of solid tumors to Stage 2 of FDA biomarker qualification

000

FDA

8/17/2021

$248,614

All Categories

About

Search

Reports

Data Submission

Recipient Information

CCS ASSOCIATES, INC.

Address: 2107 N 1ST ST SAN JOSE, CA 95131-2026

County: SANTA CLARA

Country: UNITED STATES

UEI: VCNRS52G5PG7

Issue Date FY Summary

Issue Date FY by OPDIV

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer